Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Reactive Oxygen Species in the Pathogenesis of Diabetic Complications

This study has been completed.
Sponsor:
Collaborators:
Juvenile Diabetes Research Foundation
National Institutes of Health (NIH)
Information provided by:
Albert Einstein College of Medicine of Yeshiva University
ClinicalTrials.gov Identifier:
NCT00703989
First received: June 23, 2008
Last updated: NA
Last verified: June 2008
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2008
  Primary Completion Date: October 2006 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):